Bioventus Files for $150MM IPO

Original, published 7/1/16: Bioventus registered for an initial public offering that it plans to use to pay off debt. The IPO registration put a placeholder amount of US $150MM, but that number is likely to change when Bioventus prices the flotation.

Bioventus formed in 2012 when Smith & Nephew spun out its biologics and clinical...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us